This section provides news and developments at member companies.
NuView Life Sciences is a biotechnology company based in Park City, Utah that is focused on precision cancer diagnostics and therapeutics improving patient outcomes and reducing healthcare costs. Founded in 2005, their […]
VPAC1 biomarkers are expressed on cell surfaces in high densities at the onset of oncogenesis. When VPAC1 receptors are targeted, cancer can be diagnosed early, but specifically, it allows physicians to distinguish […]
Travera’s new technology can predict how patients will respond to hundreds of different drugs or drug combinations before the patients even take the drugs. Their new measurement tool, the Suspended Microchannel Resonator […]
Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is currently an unmet medical need. Soligenix is a biotherapeutic business segment dedicated to […]
NFCR Press Release NFCR Writer David Perry August 6, 2018 In 2016, archeologists working in the Swartkrans Cave in South Africa found a piece of foot bone belonging to a hominid dating […]
NCI Press Release July 17, 2018 The largest coordinated research effort to study biological and non-biological factors associated with aggressive prostate cancer in African-American men has begun. The $26.5 million study is […]
NCI Press Release July 10, 2018 Veterans with cancer who receive treatment from the Department of Veterans Affairs (VA) will now have easier access to clinical trials of novel cancer treatments, thanks […]
David Perry NFCR Writer June 25, 2018 It is established medical fact that either heating or freezing a cancer cell can kill it, but a new treatment out of the State University […]
